Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C.

Jung Hwan YuJung Il LeeKwan Sik LeeJa Kyung Kim

Published in: Virology journal (2017)

In Korean patients with genotype 1b CHC, 20.4% (29 of 142) of patients showed RAVs against NS5A inhibitors. Patient without RAVs who received treatment with DCV + ASV showed high virologic response rates in Korea.

Keyphrases

hepatitis c virus
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
risk factors
prognostic factors
peritoneal dialysis
case report
hiv infected
copy number
antiretroviral therapy
patient reported outcomes
dna methylation
dengue virus
cell therapy
genome wide
chemotherapy induced